Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

QuantiFERON-TB Performs Better in Children, Including Infants, than in Adults with Active Tuberculosis: a Multicenter Study.

Lombardi G, Pellegrino MT, Denicolò A, Corsini I, Tadolini M, Bergamini BM, Meacci M, Garazzino S, Peracchi M, Lanari M, Re MC, Dal Monte P.

J Clin Microbiol. 2019 Sep 24;57(10). pii: e01048-19. doi: 10.1128/JCM.01048-19. Print 2019 Oct.

PMID:
31391228
2.

Relevance of vitamin D deficiency in patients with chronic autoimmune atrophic gastritis: a prospective study.

Massironi S, Cavalcoli F, Zilli A, Del Gobbo A, Ciafardini C, Bernasconi S, Felicetta I, Conte D, Peracchi M.

BMC Gastroenterol. 2018 Nov 8;18(1):172. doi: 10.1186/s12876-018-0901-0.

3.

Disseminated Mycobacterium chimaera infection after open heart surgery in an Italian woman: a case report and a review of the literature.

Chiesi S, Piacentini D, Salerno ND, Luise D, Peracchi M, Concia E, Cazzadori A, Piovan E, Lanzafame M.

Infez Med. 2017 Sep 1;25(3):267-269. Review.

4.

Comparison of the Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot and CMV QuantiFERON Cell-Mediated Immune Assays in CMV-Seropositive and -Seronegative Pregnant and Nonpregnant Women.

Saldan A, Forner G, Mengoli C, Tinto D, Fallico L, Peracchi M, Gussetti N, Palù G, Abate D.

J Clin Microbiol. 2016 May;54(5):1352-6. doi: 10.1128/JCM.03128-15. Epub 2016 Mar 9.

5.

Chromogranin A and other enteroendocrine markers in inflammatory bowel disease.

Massironi S, Zilli A, Cavalcoli F, Conte D, Peracchi M.

Neuropeptides. 2016 Aug;58:127-34. doi: 10.1016/j.npep.2016.01.002. Epub 2016 Jan 12. Review.

PMID:
26804239
6.

Intermittent treatment of recurrent type-1 gastric carcinoids with somatostatin analogues in patients with chronic autoimmune atrophic gastritis.

Massironi S, Zilli A, Fanetti I, Ciafardini C, Conte D, Peracchi M.

Dig Liver Dis. 2015 Nov;47(11):978-83. doi: 10.1016/j.dld.2015.07.155. Epub 2015 Aug 8.

PMID:
26321479
7.

Chromogranin A in diagnosing and monitoring patients with gastroenteropancreatic neuroendocrine neoplasms: a large series from a single institution.

Massironi S, Rossi RE, Casazza G, Conte D, Ciafardini C, Galeazzi M, Peracchi M.

Neuroendocrinology. 2014;100(2-3):240-9. doi: 10.1159/000369818. Epub 2014 Nov 18.

PMID:
25428270
8.

Therapy for metastatic pancreatic neuroendocrine tumors.

Rossi RE, Massironi S, Conte D, Peracchi M.

Ann Transl Med. 2014 Jan;2(1):8. doi: 10.3978/j.issn.2305-5839.2013.03.01. Review.

9.

An esophageal gastrointestinal stromal tumor in a patient with MEN1-related pancreatic gastrinoma: an unusual association and review of the literature.

Massironi S, Rossi RE, Ferrero S, Cavalcoli F, Spampatti MP, Conte D, Corbetta S, Peracchi M.

J Cancer Res Ther. 2014 Apr-Jun;10(2):443-5. doi: 10.4103/0973-1482.136685. Review.

10.

Gastrinoma and neurofibromatosis type 2: the first case report and review of the literature.

Massironi S, Zilli A, Rossi RE, Cavalcoli F, Conte D, Peracchi M.

BMC Gastroenterol. 2014 Jun 24;14:110. doi: 10.1186/1471-230X-14-110. Review.

11.

Four year longitudinal study of Mycobacterium tuberculosis complex isolates in a region of North-Eastern Italy.

Fallico L, Couvin D, Peracchi M, Pascarella M, Franchin E, Lavezzo E, Rassu M, Manganelli R, Rastogi N, Palù G.

Infect Genet Evol. 2014 Aug;26:58-64. doi: 10.1016/j.meegid.2014.05.004. Epub 2014 May 10.

PMID:
24820340
12.

Tuberculosis of the eye in Italy: a forgotten extrapulmonary localization.

Tognon MS, Fiscon M, Mirabelli P, Graziani G, Peracchi M, Sattin A, Marinello S, Vianello F, Sgarabotto D.

Infection. 2014 Apr;42(2):335-42. doi: 10.1007/s15010-013-0554-4. Epub 2013 Nov 26.

PMID:
24277596
13.

Comparison of cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV quantiferon gamma interferon-releasing assays in assessing risk of CMV infection in kidney transplant recipients.

Abate D, Saldan A, Mengoli C, Fiscon M, Silvestre C, Fallico L, Peracchi M, Furian L, Cusinato R, Bonfante L, Rossi B, Marchini F, Sgarabotto D, Rigotti P, Palù G.

J Clin Microbiol. 2013 Aug;51(8):2501-7. doi: 10.1128/JCM.00563-13. Epub 2013 May 15. Erratum in: J Clin Microbiol. 2014 Mar;52(3):1025.

14.

Chronic autoimmune atrophic gastritis associated with primary hyperparathyroidism: a transversal prospective study.

Massironi S, Cavalcoli F, Rossi RE, Conte D, Spampatti MP, Ciafardini C, Verga U, Beck-Peccoz P, Peracchi M.

Eur J Endocrinol. 2013 Apr 15;168(5):755-61. doi: 10.1530/EJE-12-1067. Print 2013 May.

PMID:
23447517
15.

Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions.

Scalabrino G, Veber D, Briani C, Milani S, Terralavoro A, Brenna S, Valenti L, Silani V, Morelli C, Peracchi M.

J Clin Neurosci. 2013 Jan;20(1):134-8. doi: 10.1016/j.jocn.2012.08.004. Epub 2012 Nov 10.

PMID:
23146213
16.

Treatment of liver metastases in patients with digestive neuroendocrine tumors.

Rossi RE, Massironi S, Spampatti MP, Conte D, Ciafardini C, Cavalcoli F, Peracchi M.

J Gastrointest Surg. 2012 Oct;16(10):1981-92. Epub 2012 Jul 25. Review.

PMID:
22829240
17.

Outbreak of transient conversions of the QuantiFERON-TB Gold In-Tube test in laboratory health care worker screenings.

Zanetti C, Peracchi M, Zorzi D, Fiorio S, Fallico L, Palù G.

Clin Vaccine Immunol. 2012 Jun;19(6):954-60. doi: 10.1128/CVI.05718-11. Epub 2012 Apr 18.

18.

Unusually aggressive type 1 gastric carcinoid: a case report with a review of the literature.

Spampatti MP, Massironi S, Rossi RE, Conte D, Sciola V, Ciafardini C, Ferrero S, Lodi L, Peracchi M.

Eur J Gastroenterol Hepatol. 2012 May;24(5):589-93. doi: 10.1097/MEG.0b013e328350fae8. Review.

PMID:
22465973
19.

Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors.

Massironi S, Conte D, Sciola V, Spampatti MP, Ciafardini C, Valenti L, Rossi RE, Peracchi M.

Am J Gastroenterol. 2010 Sep;105(9):2072-8. doi: 10.1038/ajg.2010.154. Epub 2010 Apr 6.

PMID:
20372113
20.

Contrast-enhanced ultrasonography in evaluating hepatic metastases from neuroendocrine tumours.

Massironi S, Conte D, Sciola V, Pirola L, Paggi S, Fraquelli M, Ciafardini C, Spampatti MP, Peracchi M.

Dig Liver Dis. 2010 Sep;42(9):635-41. doi: 10.1016/j.dld.2010.01.009. Epub 2010 Feb 20.

PMID:
20172770
21.

Gastric carcinoids: between underestimation and overtreatment.

Massironi S, Sciola V, Spampatti MP, Peracchi M, Conte D.

World J Gastroenterol. 2009 May 14;15(18):2177-83.

22.

Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity.

Eller-Vainicher C, Chiodini I, Battista C, Viti R, Mascia ML, Massironi S, Peracchi M, D'Agruma L, Minisola S, Corbetta S, Cole DE, Spada A, Scillitani A.

J Bone Miner Res. 2009 Aug;24(8):1404-10. doi: 10.1359/jbmr.090304.

23.

Plasma chromogranin a in patients with inflammatory bowel disease.

Sciola V, Massironi S, Conte D, Caprioli F, Ferrero S, Ciafardini C, Peracchi M, Bardella MT, Piodi L.

Inflamm Bowel Dis. 2009 Jun;15(6):867-71. doi: 10.1002/ibd.20851.

PMID:
19090560
24.

Neuroendocrine tumors of the gastro-entero-pancreatic system.

Massironi S, Sciola V, Peracchi M, Ciafardini C, Spampatti MP, Conte D.

World J Gastroenterol. 2008 Sep 21;14(35):5377-84. Review.

25.

Chromogranin A levels in chronic liver disease and hepatocellular carcinoma.

Massironi S, Fraquelli M, Paggi S, Sangiovanni A, Conte D, Sciola V, Ciafardini C, Colombo M, Peracchi M.

Dig Liver Dis. 2009 Jan;41(1):31-5. doi: 10.1016/j.dld.2008.05.002. Epub 2008 Aug 30.

PMID:
18762462
26.

Evaluation of IGF-I levels during long-term somatostatin analogs treatment in patients with gastroenteropancreatic endocrine tumors.

Ronchi CL, Peracchi M, Corbetta S, Massironi S, Ciafardini C, Conte D, Beck-Peccoz P, Spada A.

J Endocrinol Invest. 2007 Mar;30(3):241-6.

PMID:
17505159
27.

New insights into the pathophysiology of cobalamin deficiency.

Scalabrino G, Peracchi M.

Trends Mol Med. 2006 Jun;12(6):247-54. Epub 2006 May 11.

PMID:
16690356
28.

Circulating ghrelin levels in patients with inflammatory bowel disease.

Peracchi M, Bardella MT, Caprioli F, Massironi S, Conte D, Valenti L, Ronchi C, Beck-Peccoz P, Arosio M, Piodi L.

Gut. 2006 Mar;55(3):432-3. No abstract available.

29.

Hypokalemic rhabdomyolysis without watery diarrhea: an unexpected presentation of a pancreatic neuro-endocrine tumor.

Rossi V, Saibeni S, Sinigaglia L, Peracchi M, Parafioriti A, Vecchi M.

Am J Gastroenterol. 2006 Mar;101(3):669-72. Epub 2006 Feb 8.

PMID:
16464230
30.

Post-traumatic headache from moderate head injury.

Moscato D, Peracchi MI, Mazzotta G, Savi L, Battistella PA.

J Headache Pain. 2005 Sep;6(4):284-6.

31.

A follow-up study of patients with Zollinger-Ellison syndrome in the period 1966-2002: effects of surgical and medical treatments on long-term survival.

Quatrini M, Castoldi L, Rossi G, Cesana BM, Peracchi M, Bardella MT.

J Clin Gastroenterol. 2005 May-Jun;39(5):376-80.

PMID:
15815204
32.

Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids.

Peracchi M, Gebbia C, Basilisco G, Quatrini M, Tarantino C, Vescarelli C, Massironi S, Conte D.

Eur J Endocrinol. 2005 Mar;152(3):443-8.

PMID:
15757862
33.

Cerebellar degeneration and hearing loss in a patient with idiopathic myenteric ganglionitis.

Basilisco G, Gebbia C, Peracchi M, Velio P, Conte D, Bresolin N, Nobile-Orazio E.

Eur J Gastroenterol Hepatol. 2005 Apr;17(4):449-52.

PMID:
15756099
34.

High tumor necrosis factor-alpha [corrected] levels in cerebrospinal fluid of cobalamin-deficient patients.

Scalabrino G, Carpo M, Bamonti F, Pizzinelli S, D'Avino C, Bresolin N, Meucci G, Martinelli V, Comi GC, Peracchi M.

Ann Neurol. 2004 Dec;56(6):886-90. Erratum in: Ann Neurol. 2005 Feb;57(2):304.

PMID:
15562428
35.

Effects of modified sham feeding on ghrelin levels in healthy human subjects.

Arosio M, Ronchi CL, Beck-Peccoz P, Gebbia C, Giavoli C, Cappiello V, Conte D, Peracchi M.

J Clin Endocrinol Metab. 2004 Oct;89(10):5101-4.

PMID:
15472212
36.

Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.

Zignol M, Peracchi M, Tridello G, Pillon M, Fregonese F, D'Elia R, Zanesco L, Cesaro S.

Cancer. 2004 Aug 1;101(3):635-41.

37.

Searching for coeliac disease in patients with non-alcoholic fatty liver disease.

Bardella MT, Valenti L, Pagliari C, Peracchi M, Farè M, Fracanzani AL, Fargion S.

Dig Liver Dis. 2004 May;36(5):333-6.

PMID:
15191202
38.

Gallstone disease and related risk factors in a large cohort of diabetic patients.

Pagliarulo M, Fornari F, Fraquelli M, Zoli M, Giangregorio F, Grigolon A, Peracchi M, Conte D.

Dig Liver Dis. 2004 Feb;36(2):130-4.

PMID:
15002821
39.

Ghrelin administration affects circulating pituitary and gastro-entero-pancreatic hormones in acromegaly.

Arosio M, Ronchi CL, Gebbia C, Pizzinelli S, Conte D, Cappiello V, Epaminonda P, Cesana BM, Beck-Peccoz P, Peracchi M.

Eur J Endocrinol. 2004 Jan;150(1):27-32.

PMID:
14713276
40.

Circulating ghrelin levels in celiac patients.

Peracchi M, Conte D, Terrani C, Pizzinelli S, Gebbia C, Cappiello V, Spada A, Bardella MT.

Am J Gastroenterol. 2003 Nov;98(11):2474-8.

PMID:
14638351
41.

Elevated circulating somatostatin levels in acromegaly.

Arosio M, Porretti S, Epaminonda P, Giavoli C, Gebbia C, Penati C, Beck-Peccoz P, Peracchi M.

J Endocrinol Invest. 2003 Jun;26(6):499-502.

42.

Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: identification of one pancreatic ghrelinoma.

Corbetta S, Peracchi M, Cappiello V, Lania A, Lauri E, Vago L, Beck-Peccoz P, Spada A.

J Clin Endocrinol Metab. 2003 Jul;88(7):3117-20.

PMID:
12843152
43.

Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels.

Arosio M, Ronchi CL, Gebbia C, Cappiello V, Beck-Peccoz P, Peracchi M.

J Clin Endocrinol Metab. 2003 Feb;88(2):701-4.

44.

Plasma chromogranin A in patients with sporadic gastro-entero-pancreatic neuroendocrine tumors or multiple endocrine neoplasia type 1.

Peracchi M, Conte D, Gebbia C, Penati C, Pizzinelli S, Arosio M, Corbetta S, Spada A.

Eur J Endocrinol. 2003 Jan;148(1):39-43.

PMID:
12534356
45.

Tissue transglutaminase antibodies in patients with end-stage heart failure.

Peracchi M, Trovato C, Longhi M, Gasparin M, Conte D, Tarantino C, Prati D, Bardella MT.

Am J Gastroenterol. 2002 Nov;97(11):2850-4.

PMID:
12425559
46.

Prokinetic effect of Alka-Seltzer in healthy subjects.

Gebbia C, Baldassarri A, Manenti S, Pignattelli S, Peracchi M.

Dig Liver Dis. 2002 May;34(5):385. No abstract available.

PMID:
12118961
47.

High frequency of anti-endomysial reactivity in candidates to heart transplant.

Prati D, Bardella MT, Peracchi M, Porretti L, Cardillo M, Pagliari C, Tarantino C, Della TE, Scalamogna M, Bianchi PA, Sirchia G, Conte D; North Italy Transplant Programme Working Group (NITp).

Dig Liver Dis. 2002 Jan;34(1):39-43.

PMID:
11926572
48.

Antiendomysial antibodies in patients with end-stage heart failure.

Prati D, Bardella MT, Peracchi M, Porretti L, Scalamogna M, Conte D.

Am J Gastroenterol. 2002 Jan;97(1):218-9. No abstract available.

PMID:
11808964
49.

Human cobalamin deficiency: alterations in serum tumour necrosis factor-alpha and epidermal growth factor.

Peracchi M, Bamonti Catena F, Pomati M, De Franceschi M, Scalabrino G.

Eur J Haematol. 2001 Aug;67(2):123-7.

PMID:
11722601
50.

Serological markers for coeliac disease: is it time to change?

Bardella MT, Trovato C, Cesana BM, Pagliari C, Gebbia C, Peracchi M.

Dig Liver Dis. 2001 Jun-Jul;33(5):426-31.

PMID:
11529655

Supplemental Content

Loading ...
Support Center